Article
A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients
11 Mar 2019
Abstract excerpt
BACKGROUND: Glioblastoma (GBM) remains the most biologically aggressive subtype of gliomas with an average survival of 10 to 12 months. Considering that the overall survival (OS) of each GBM patient is a key factor in the treatment of individuals, it is meaningful to predict the survival probability for GBM patients newly diagnosed in clinical practice. MATERIAL AND METHODS: Using the TCGA dataset and two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
